A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma Meeting Abstract
| Authors: | Makker, V.; Rasco, D. W.; Dutcus, C. E.; Stepan, D. E.; Li, D.; Schmidt, E. V.; Shumaker, R. C.; Taylor, M. H. |
| Abstract Title: | A phase Ib/II trial of lenvatinib (LEN) plus pembrolizumab (Pembro) in patients (Pts) with endometrial carcinoma |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 310s |
| Language: | English |
| ACCESSION: | WOS:000411931704075 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.5598 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5598 -- Source: Wos |
